Kairos PharmaKAPA
13F holders, Q2 2026 (June 30)14holders +3
7new positions
4sold out
1famous investor
$0.38avg. 13F price*
At the end of Q2 2026, 14 institutions reported holding Kairos Pharma Ltd. (KAPA) in their 13F filings, up 3 from Q1 2026. 7 opened new positions and 4 sold out. The largest holders were Citadel Advisors ($119K), Vanguard Capital Management LLC ($89K) and Virtu Financial LLC ($31K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Kairos Pharma Ltd.
- CUSIP
- 48301N104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $182K |
| Exits | 4 | $43K |
All 13F filers, Q1 2026 → Q2 2026: 476,869 shares bought and 109,970 shares sold, net +366,899 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 14 holders
| Citadel Advisors | 0.00% | New | 309,834 | $119K |
| Vanguard Capital Management LLC | 0.00% | No change | 231,878 | $89K |
| Virtu Financial LLC | 0.00% | New | 82,092 | $31K |
| Geode Capital Management, LLC | 0.00% | Reduce -29.1% | 78,924 | $30K |
| Vanguard Fiduciary Trust Co. | 0.00% | No change | 63,884 | $25K |
| SevenBridge Financial Group, LLC | 0.00% | No change | 44,286 | $17K |
| Aptus Capital Advisors, LLC | 0.00% | No change | 44,286 | $17K |
| Jane Street Group, LLC | 0.00% | New | 33,749 | $13K |
| Susquehanna International Group, LLP | 0.00% | New | 29,292 | $11K |
| State Street Corp. | 0.00% | No change | 24,100 | $9K |
| XTX Topco Ltd | 0.00% | New | 14,918 | $6K |
| UBS Group AG | 0.00% | New | 6,261 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -5.8% | 3,733 | $1K |
| Barclays PLC | 0.00% | New | 723 | $277 |
"% of holder's portfolio" is KAPA's weight in each manager's 13F, not the share of Kairos Pharma Ltd. the manager owns.